drugset
drugset / Trial / NCT05147766

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease

NCT05147766 ↗

Phase 1 Terminated 3 enrolled The Foundation for Orthopaedics and Regenerative Medicine
NaSingle-groupOpen-labelTreatment

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of congestive heart failure and angina

Timeline

Start
2022-02-01
Primary completion
2025-04-03
Completion
2025-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AlloRx Cell therapy 100 cells Intravenous

Indications

congestive heart failure